Inhibitors of cdc phosphatases
US8017637B2 · kind B2 · utility
8Cited by
3References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 16, 2005 |
| Grant date | Sep 13, 2011 |
| Priority date | — |
| Expiry date | Apr 25, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D277/64
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A subject of the present invention is novel compounds comprising 2 or 3 benzothiazole-4,7-dione- or benzooxazole-4,7-dione-type units, which inhibit the cdc25 phosphatases, in particular cdc25-C phosphatase. These compounds can in particular be used in the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.